Look for Pharma Talent with Fleming Europe
News Feb 27, 2012
Staying competitive in the pharmaceutical industry requires the ability to bridge gaps between multi-disciplinary areas such as science, business, law and public relations. The most successful pharma and biotech companies know that behind the success is a pool of talented personnel that are able to think outside the box and adapt to an ever-evolving environment.
Fleming Europe has organized the Talent Forward 2012, its 7th edition of the successful Pharma HR series. The event will take place in the comfort of the Hotel Rey Juan Carlos I, in Barcelona on 3 – 4 May 2012.
The Masterclass session, “Aligning organizational coaching to talent management strategy,” will be the center of attention. Facilitated by Dr. Paul Turner, Honorary research fellow from Birmingham city university, UK, will concentrate on talent challenges in the pharma industry, various dimensions of talent management, and coaching & relationship management capability.
The Talent forward 2012 survey, currently available online, will conclude the afternoon session. The evaluation and results advices will be presented and discussed.
The 2-day conference will be rich in topics and will cover all the stages in the pharma talent life-cycle – innovative pharma HR talent acquisition, finding talent for special positions, developments in talent mapping, examples of the most effective talent development programs, clever talent retention and reengagement and the influence of popular social media.
Panel discussions enabling the interaction with prominent speakers from Pfizer, Sanofi Aventis, GlaxoSmithKline, Eli Lilly, Abbott, Amgen, Sandoz, Nycomed, Merck, Shire, etc. are scheduled throughout the conference.
The pharmaceutical industry of developed economies is already saturated with a dedicated workforce. In emerging markets pharma companies have to fight for qualified personnel. How to “capture & hire” is only the first step to take. How to retain such talent is the vital question these companies need to answer.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018